Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients

Alzheimers Dement. 2009 Mar;5(2):143-6. doi: 10.1016/j.jalz.2009.01.013.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / prevention & control
  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Brain / physiopathology*
  • Brain Injuries / drug therapy*
  • Brain Injuries / physiopathology
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards*
  • Disease Models, Animal
  • Drug Design*
  • Humans
  • Nerve Degeneration / etiology
  • Nerve Degeneration / pathology
  • Nerve Degeneration / physiopathology*
  • Neurofibrillary Tangles / metabolism
  • Neurofibrillary Tangles / pathology
  • Plaque, Amyloid / metabolism
  • Plaque, Amyloid / pathology
  • Public-Private Sector Partnerships / standards
  • Stroke / drug therapy
  • Stroke / physiopathology